Thermo Fisher Q2: rev +3% to $10.85B, GAAP EPS $4.28 (+6%), adj EPS $5.36

THERMO FISHER SCIENTIFIC INC.

2025-Q2 EPS reported $8.26 revenue$21,219,000,000

Q2 revenue $10.85B (+3% YoY; organic 2%); GAAP diluted EPS $4.28, up 6% from $4.04.
Adjusted EPS $5.36 (vs $5.37); GAAP op margin 16.9% (down 40bps); adj op margin 21.9% (down 40bps).
2025 annual guidance to be updated during today's earnings call.
New product launches: Orbitrap Astral Zoom MS, Krios 5 Cryo-TEM, DynaDrive bioreactor bench scale.
Post-quarter: expanded Sanofi partnership, acquiring Ridgefield, NJ sterile fill-finish site.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.